Relationship betweenp53 gene abnormalities and other tumour characteristics in breast-cancer prognosis

This publication has 25 references indexed in Scilit:

• Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy
  Nature Medicine, 1995
• Cell kinetics in human breast cancer: Comparison between the prognostic value of the cytofluorimetric S‐phase fraction and that of the antibodies to Ki‐67 and PCNA antigens detected by immunocytochemistry
  International Journal of Cancer, 1994
• Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors
  JNCI Journal of the National Cancer Institute, 1994
• P53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment
  Cancer, 1994
• Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.
  Journal of Clinical Oncology, 1994
• Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis?
  Human Pathology, 1993
• Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast Cancer
  JNCI Journal of the National Cancer Institute, 1993
• Cell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki-67 antibodies: Its prognostic value on short-term recurrences
  European Journal Of Cancer, 1993
• Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections
  The Journal of Pathology, 1992
• Theoretical Statistics
  Published by Springer Nature ,1974